Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Goldfine

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cell Metabolism|May 7, 2009
Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketonesXiaohui L Wang, Ryo Suzuki, Kevin Lee, et al.
Circulation|May 14, 2003
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinedionesNerea Varo, David Vicent, Peter Libby, et al.
Clinical Epigenetics|March 20, 2025
Type 2 diabetes impacts DNA methylation in human spermLei Su, Jonathan M Dreyfuss, Rafael Ferraz Bannitz, et al.
Nature Communications|November 30, 2021
High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes controlJonathan M Dreyfuss, Yixing Yuchi, Xuehong Dong, et al.
Plos One|March 27, 2015
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesGeoffrey A Walford, Natalia Colomo, Jennifer N Todd, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cell Metabolism|May 7, 2009
Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketonesXiaohui L Wang, Ryo Suzuki, Kevin Lee, et al.
Circulation|May 14, 2003
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinedionesNerea Varo, David Vicent, Peter Libby, et al.
Clinical Epigenetics|March 20, 2025
Type 2 diabetes impacts DNA methylation in human spermLei Su, Jonathan M Dreyfuss, Rafael Ferraz Bannitz, et al.
Nature Communications|November 30, 2021
High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes controlJonathan M Dreyfuss, Yixing Yuchi, Xuehong Dong, et al.
Plos One|March 27, 2015
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetesGeoffrey A Walford, Natalia Colomo, Jennifer N Todd, et al.
Pageof 2